This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Hepatic blood flow, protein, carbohydrate, and lipid metabolism, drug and toxin detoxification and excretion, and bile synthesis and removal are only some of the functions of the liver. The range of liver disease is exceedingly broad, with many underlying disorders presenting in both acute and chronic forms. Autoimmune diseases, viral infection, and toxic insult account for the majority of the underlying pathogenetic pathways. Treatment of the symptoms and complications that occur, as well as medication therapy related to the underlying condition, are all part of any liver disease management approach.
Diseases of the bile ducts, gallbladder, and other structures involved in the formation and transportation of bile are referred to as biliary disease. Bile may be a digestive juice that's produced by the liver. The chance of developing biliary disorder is increased by heredity, advancing age, obesity, a high-fat diet, certain gastrointestinal diseases, and certain prescription drugs.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States